cdk4 glutathione

cdk4 glutathione Metabolic Reprogramming of Pancreatic Cancer Mediated by CDK4/6 Inhibition Elicits Unique Vulnerabilities Cyclin D-Cdk4,6 Drives Cell-Cycle Progression

Name: cdk4 glutathione Metabolic Reprogramming of Pancreatic Cancer Mediated by CDK4/6 Inhibition Elicits Unique Vulnerabilities Cyclin D-Cdk4,6 Drives Cell-Cycle Progression
Brand: equiscorp.hu
SKU: 2536754556
Price: 21.52 USD
Availability: InStock
Rating: 4.3807 (8 reviews)

Cyclin D Cdk4,6 Drives Cell Cycle Progression via the Retinoblastoma Protein's C Terminal Helix PMC Breaking Cancer's Momentum: CDK4 6 Inhibitors and the Promise of Combination Therapy PMC MYC induces CDK4 6 inhibitors resistance by promoting pRB1 degradation Nature Communications Multistep activation of CDK4. CDK4 activation requires (i) increased Download Scientific Diagram

SKU: 2536754556 · From equiscorp.hu

4.4

USD21.52 USD50.52

Pay in 4 interest-free payments of $5.38 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 4 - Aug 9

Description

A later study in normal volunteers showed that a methaemoglobin level of 6% was produced by the intravenous injection of 1 mg sodium nitrite per kg (about 300 mg, 10 ml of a 3% solution of sodium nitrite) (Weger, 1968)